Nanocomposite Formulation for Therapy of Ocular Diseases

To improve the anti-angiogenic or anti-inflammatory effects, a dual-drug nanocomposite formulation was proposed for the therapy for ocular vascular diseases.

Related Keywords

China ,Japan ,United States ,United Kingdom ,American ,Micrometrics Tristar ,Cell Systems Corporation United Kingdom ,Qinglongshan Experimental Animal Center ,Vision Research ,Zetasizer Malvern Instrument ,Release Study ,Cell Systems Corporation ,American Tissue Culture Collection ,Molecular Devices ,Induced Inflammatory Response ,Animal Care ,Use Committee ,Periodic Acid Schiff ,Whitneyu Test ,Drug Loading Efficiency ,Nanocarrier Has No Obvious Cytotoxicity ,Complex Formulation Suppresses Angiogenic Effects ,Inflammatory Responses ,Complex Formulation Suppresses ,Related Inflammatory ,